drugset / Trial / NCT00045955

Long-Term Safety Performance of Fexofenadine in Asthma

NCT00045955

Phase 3 Completed 1200 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma

Timeline

Start
2002-02
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown
Subject Montelukast Other / unclassified Oral

Indications